InMed Pharmaceuticals Inc. (INM) (CIK 0001728328) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001213900-26-034689
- Form
- CORRESP
- Filer
- InMed Pharmaceuticals Inc. (INM) (CIK 0001728328)
- CIK
- 0001728328
- Ticker
- INM
- Filed
- 2026-03-26
- SIC industry
- 2834
- HQ
- Vancouver, A1
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1728328/000121390026034689/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer